Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.57 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.24.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.42.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.14.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used